These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Homing in on genomic instability as a therapeutic target in cancer. Bielski CM; Taylor BS Nat Commun; 2021 Jun; 12(1):3663. PubMed ID: 34135330 [TBL] [Abstract][Full Text] [Related]
23. The evolving clinical testing landscape of genomic aberrations in solid tumors and hematological malignancies - Insights from evidence-based reviews for B-ALL and breast, brain, and renal cell neoplasia. Miron PM; Fang M Cancer Genet; 2020 Jun; 244():60-61. PubMed ID: 32473557 [No Abstract] [Full Text] [Related]
24. Sequencing set to alter clinical landscape. Hayden EC Nature; 2012 Feb; 482(7385):288. PubMed ID: 22337027 [No Abstract] [Full Text] [Related]
26. Next generation sequencing in cancer: opportunities and challenges for precision cancer medicine. Paolillo C; Londin E; Fortina P Scand J Clin Lab Invest Suppl; 2016; 245():S84-91. PubMed ID: 27542004 [TBL] [Abstract][Full Text] [Related]
27. Separating hype from reality in the era of the affordable genome. Collier R CMAJ; 2012 Apr; 184(6):E287-8. PubMed ID: 22371514 [No Abstract] [Full Text] [Related]
28. In need of counseling? Nat Biotechnol; 2008 Jul; 26(7):716. PubMed ID: 18612273 [TBL] [Abstract][Full Text] [Related]
29. Barriers preventing the adoption of comprehensive cancer genomic profiling in the clinic. Statz CM; Patterson SE; Mockus SM Expert Rev Mol Diagn; 2017 Jun; 17(6):549-555. PubMed ID: 28402162 [TBL] [Abstract][Full Text] [Related]
31. Genomic testing in oncology to improve clinical outcomes while optimizing utilization: the evolution of diagnostic testing. Collymore DC; Kobilis SL; Lundquist TG; McGivney WT; Pezalla EJ; Poage W Am J Manag Care; 2016 Feb; 22(2 Suppl):s20-5. PubMed ID: 26978033 [TBL] [Abstract][Full Text] [Related]
32. The detection and implication of genome instability in cancer. Pikor L; Thu K; Vucic E; Lam W Cancer Metastasis Rev; 2013 Dec; 32(3-4):341-52. PubMed ID: 23633034 [TBL] [Abstract][Full Text] [Related]
33. Genomic future beckons for cancer management. Qadir Z Lancet; 2011 Nov; 378(9806):1838. PubMed ID: 22125803 [No Abstract] [Full Text] [Related]
34. The DNA of a nation. Marx V Nature; 2015 Aug; 524(7566):503-5. PubMed ID: 26310768 [No Abstract] [Full Text] [Related]
35. Towards identification of true cancer biomarkers. Diamandis EP BMC Med; 2014 Sep; 12():156. PubMed ID: 25220599 [TBL] [Abstract][Full Text] [Related]
36. Large-scale genome projects enter the clinic on both sides of the Atlantic. Tuma RS J Natl Cancer Inst; 2011 Dec; 103(23):1730-1. PubMed ID: 22100583 [No Abstract] [Full Text] [Related]
37. Genomics: gearing up for the laboratory of the future. Glorikian H MLO Med Lab Obs; 2014 Feb; 46(2):8, 11. PubMed ID: 24672844 [No Abstract] [Full Text] [Related]
38. The human genome at ten. Nature; 2010 Apr; 464(7289):649-50. PubMed ID: 20360688 [No Abstract] [Full Text] [Related]
39. The current clinical value of genomic instability. Diaz LA Semin Cancer Biol; 2005 Feb; 15(1):67-71. PubMed ID: 15613290 [TBL] [Abstract][Full Text] [Related]
40. Whole Genome Amplification in Genomic Analysis of Single Circulating Tumor Cells. Gasch C; Pantel K; Riethdorf S Methods Mol Biol; 2015; 1347():221-32. PubMed ID: 26374320 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]